Laidlaw Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-509
| Closed | -$447K | – | 224 |
|
|
2023
Q4 | $447K | Buy |
509
+132
| +35% | +$116K | 0.16% | 140 |
|
|
2023
Q3 | $310K | Sell |
377
-56
| -13% | -$46.1K | 0.1% | 196 |
|
|
2023
Q2 | $311K | Sell |
433
-39
| -8% | -$28K | 0.06% | 261 |
|
|
2023
Q1 | $388K | Hold |
472
| – | – | 0.08% | 230 |
|
|
2022
Q4 | $341K | Sell |
472
-2
| -0.4% | -$1.44K | 0.07% | 250 |
|
|
2022
Q3 | $327K | Buy |
474
+34
| +8% | +$23.5K | 0.08% | 225 |
|
|
2022
Q2 | $260K | Hold |
440
| – | – | 0.05% | 296 |
|
|
2022
Q1 | $307K | Sell |
440
-2
| -0.5% | -$1.4K | 0.05% | 297 |
|
|
2021
Q4 | $279K | Buy |
442
+5
| +1% | +$3.16K | 0.04% | 321 |
|
|
2021
Q3 | $264K | Sell |
437
-3
| -0.7% | -$1.81K | 0.07% | 199 |
|
|
2021
Q2 | $246K | Buy |
+440
| New | +$246K | 0.06% | 218 |
|
|
2021
Q1 | – | Sell |
-431
| Closed | -$208K | – | 327 |
|
|
2020
Q4 | $208K | Buy |
431
+9
| +2% | +$4.34K | 0.04% | 331 |
|
|
2020
Q3 | $236K | Buy |
+422
| New | +$236K | 0.1% | 180 |
|